Literature DB >> 1912979

Nitroglycerin relaxes coronary artery of the pig with no change in glutathione content or glutathione S-transferase activity.

M Sakanashi1, T Matsuzaki, Y Aniya.   

Abstract

1. The role of glutathione content and glutathione S-transferase activity in vascular relaxant responses to nitroglycerin was evaluated in potassium (30 mM)-contracted coronary artery strips of the pig by measuring changes in tension, glutathione content and glutathione S-transferase activity. 2. Prior exposure of coronary artery strips to nitroglycerin (10(-5)M or 10(-4)M for 20 min) resulted in tachyphylaxis to subsequent relaxation to nitroglycerin (10(-8)-10(-5)M). 3. The glutathione content and glutathione S-transferase activity of the arterial strips rendered tachyphylactic by prior exposure to nitroglycerin (10(-5)M for 20 min or 10(-3)M for 120 min) were not significantly different from those of control strips. 4. Treatment with diethyl maleate (10(-4)M or 10(-3)M for 60 min) markedly depleted arterial glutathione content in a concentration-dependent manner with no change in glutathione S-transferase activity. 5. The relaxant response of coronary artery strips to nitroglycerin (10(-8)-10(-5)M) was completely unaffected following treatment with diethyl maleate (10(-4)M or 10(-3)M for 60 min). 6. The results suggest that vascular glutathione content does not play an important role in vascular relaxation or tolerance development to nitroglycerin, at least in pig isolated coronary artery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912979      PMCID: PMC1908217          DOI: 10.1111/j.1476-5381.1991.tb12350.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation.

Authors:  L J Ignarro; P J Kadowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

3.  Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base.

Authors:  W R Kukovetz; S Holzmann
Journal:  Z Kardiol       Date:  1985

4.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

Authors:  M D Winniford; P L Kennedy; P J Wells; L D Hillis
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

5.  N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.

Authors:  J H Svendsen; K Klarlund; J Aldershvile; S Waldorff
Journal:  J Cardiovasc Pharmacol       Date:  1989-02       Impact factor: 3.105

6.  Prevention and reversal of nitrate tolerance in patients with congestive heart failure.

Authors:  M Packer; W H Lee; P D Kessler; S S Gottlieb; N Medina; M Yushak
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

7.  Antagonism of glycerol trinitrate activity by an inhibitor of glutathione S-transferase.

Authors:  R A Yeates; M Schmid; M Leitold
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

8.  Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

Authors:  J Torresi; J D Horowitz; G J Dusting
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

9.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

10.  Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation.

Authors:  C A Gruetter; S M Lemke
Journal:  Eur J Pharmacol       Date:  1985-04-23       Impact factor: 4.432

View more
  9 in total

1.  Impaired vasodilator response to organic nitrates in isolated basilar arteries.

Authors:  D Martens; G Kojda
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro.

Authors:  G W He; C Q Yang
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

5.  Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.

Authors:  D Salvemini; A Pistelli; E Anggard
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Inhibitory effects of glyceryl trinitrate on alpha-adrenoceptor mediated contraction in the human internal mammary artery.

Authors:  G W He; J Shaw; C Q Yang; C Hughes; D Thomson; B McCaughan; P N Hendle; D K Baird
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

7.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.

Authors:  D Salvemini; A Pistelli; J Vane
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

9.  Interaction between endothelin and vasodilators in the human internal mammary artery.

Authors:  G W He; C Q Yang; M J Mack; T E Acuff; W H Ryan; A Starr
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.